Morepen Labs soars 10% as drugmaker looks to sell OTG biz
The stock climbed 9.87 per cent to hit a high of Rs 27.25 on BSE. This was still far from its 52-week high of Rs 41.80 the stock hit in January this year.

The stock climbed 9.87 per cent to hit a high of Rs 27.25 on BSE. This was still far from its 52-week high of Rs 41.80 the stock hit in January this year. ET quoted multiple sources as saying, “Morepen has mandated Deloitte Touche Tohmatsu to run a formal process and the negotiations are at quite an advanced stage.”
On source told ET while the company has received interest from several contenders, including some of the large buyout funds and strategic players, talks with the Piramal Group have advanced quite a bit. The source said the the transaction might conclude within a couple of months.
Download ET Markets APP